[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Michel Doepke [@doepke_michel](/creator/twitter/doepke_michel) on x 4870 followers Created: 2025-07-15 12:58:31 UTC Sino with an interesting move to acquire LaNova for up to $951M. $MRK entered into Exclusive Global License for LM-299, An Investigational Anti-PD-1/VEGF Bispecific Antibody from LaNova Medicines back in November - $588M upfront! $BNTX $SMMT $PFE  XXXXX engagements  **Related Topics** [$1177hk](/topic/$1177hk) [$bntx](/topic/$bntx) [$588m](/topic/$588m) [$951m](/topic/$951m) [$mrk](/topic/$mrk) [stocks healthcare](/topic/stocks-healthcare) [$smmt](/topic/$smmt) [$pfe](/topic/$pfe) [Post Link](https://x.com/doepke_michel/status/1945105697462513908)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Michel Doepke @doepke_michel on x 4870 followers
Created: 2025-07-15 12:58:31 UTC
Sino with an interesting move to acquire LaNova for up to $951M. $MRK entered into Exclusive Global License for LM-299, An Investigational Anti-PD-1/VEGF Bispecific Antibody from LaNova Medicines back in November - $588M upfront! $BNTX $SMMT $PFE
XXXXX engagements
Related Topics $1177hk $bntx $588m $951m $mrk stocks healthcare $smmt $pfe
/post/tweet::1945105697462513908